Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Norris

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Oncotarget|November 10, 2016
Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatmentsNabanita Mukherjee, Adam Almeida, Katie A Partyka, et al.
Cancers|August 9, 2020
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced MelanomaNabanita Mukherjee, Carol M Amato, Jenette Skees, et al.
The Journal of Investigative Dermatology|May 25, 2012
Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistanceYuchun Luo, Lixia Z Ellis, Katiuscia Dallaglio, et al.
Journal of the American Academy of Dermatology|March 18, 2018
Alopecia areata is a medical diseaseDorota Z Korta, Angela M Christiano, Wilma Bergfeld, et al.
Frontiers in Immunology|December 25, 2012
Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy aloneCarl K Edwards, Julie S Green, Hans-Dieter Volk, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
SASH1 interacts with TNKS2 and promotes human melanocyte stem cell maintenanceKaroline A Lambert, Christopher M Clements, Nabanita Mukherjee, et al.
The Journal of Investigative Dermatology|October 22, 2017
Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the β-Catenin Pathway in the Hair Follicle Bulge Stem CellsNathaniel B Goldstein, Maranke I Koster, Kenneth L Jones, et al.
The Journal of Investigative Dermatology|July 24, 2015
SASH1 Is Involved in an Autosomal Dominant Lentiginous PhenotypeYiqun G Shellman, Karoline A Lambert, Anne Brauweiler, et al.
The Journal of Investigative Dermatology|June 7, 2024
SASH1 S519N Variant Links Skin Hyperpigmentation and Premature Hair Graying to Dysfunction of Melanocyte LineageKaroline A Lambert, Christopher M Clements, Nabanita Mukherjee, et al.
The Journal of Investigative Dermatology|August 18, 2020
Melanocyte Precursors in the Hair Follicle Bulge of Repigmented Vitiligo Skin Are Controlled by RHO-GTPase, KCTD10, and CTNNB1 SignalingNathaniel B Goldstein, Andrea Steel, Chauncey C Barbulescu, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Oncotarget|November 10, 2016
Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatmentsNabanita Mukherjee, Adam Almeida, Katie A Partyka, et al.
Cancers|August 9, 2020
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced MelanomaNabanita Mukherjee, Carol M Amato, Jenette Skees, et al.
The Journal of Investigative Dermatology|May 25, 2012
Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistanceYuchun Luo, Lixia Z Ellis, Katiuscia Dallaglio, et al.
Journal of the American Academy of Dermatology|March 18, 2018
Alopecia areata is a medical diseaseDorota Z Korta, Angela M Christiano, Wilma Bergfeld, et al.
Frontiers in Immunology|December 25, 2012
Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy aloneCarl K Edwards, Julie S Green, Hans-Dieter Volk, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
SASH1 interacts with TNKS2 and promotes human melanocyte stem cell maintenanceKaroline A Lambert, Christopher M Clements, Nabanita Mukherjee, et al.
The Journal of Investigative Dermatology|October 22, 2017
Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the β-Catenin Pathway in the Hair Follicle Bulge Stem CellsNathaniel B Goldstein, Maranke I Koster, Kenneth L Jones, et al.
The Journal of Investigative Dermatology|July 24, 2015
SASH1 Is Involved in an Autosomal Dominant Lentiginous PhenotypeYiqun G Shellman, Karoline A Lambert, Anne Brauweiler, et al.
The Journal of Investigative Dermatology|June 7, 2024
SASH1 S519N Variant Links Skin Hyperpigmentation and Premature Hair Graying to Dysfunction of Melanocyte LineageKaroline A Lambert, Christopher M Clements, Nabanita Mukherjee, et al.
The Journal of Investigative Dermatology|August 18, 2020
Melanocyte Precursors in the Hair Follicle Bulge of Repigmented Vitiligo Skin Are Controlled by RHO-GTPase, KCTD10, and CTNNB1 SignalingNathaniel B Goldstein, Andrea Steel, Chauncey C Barbulescu, et al.
Pageof 8